The granular type II pneumonocyte and lung antioxidant defense

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Two cell types predominate in mammalian alveolar epithelium: Type I cells (membranous pneumonocytes), which have a small, nucleated cell body with attenuated peripheral cytoplasm containing a relative paucity of intracytoplasmic organelles, and which cover most of the alveolar surface; and Type II cells (granular pneumonocytes), which are nearly cuboidal with abundant cytoplasmic organelles, including moderate amounts of endoplasmic reticulum, ribosomes, and lamellar inclusions, and which cover areas of the alveolar surface not lined by type I cells. The lamellar inclusions of the type II cells represent sites of synthesis of pulmonary surfactant, the phospholipid rich substance primarily responsible for alveolar stability. The past few years have witnessed the ascendency of 3 other related concepts concerning the type II pneumonocyte: it participates in the injury and repair processes of pulmonary parenchymal tissue: it may be the progenitor of the more numerous type I alveolar epithelial cells; and the reparative adaptive response determines, to some extent, the susceptibility of lung parenchyma to oxidant stress. This editorial summarizes the 3 mutually complementary concepts.

Original languageEnglish (US)
Pages (from-to)409-411
Number of pages3
JournalAnnals of Internal Medicine
Volume80
Issue number3
StatePublished - 1974

Fingerprint

Antioxidants
Lung
Organelles
Alveolar Epithelial Cells
Pulmonary Surfactants
Ribosomes
Oxidants
Endoplasmic Reticulum
Phospholipids
Cytoplasm
Epithelium
Wounds and Injuries

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The granular type II pneumonocyte and lung antioxidant defense. / Cross, Carroll E.

In: Annals of Internal Medicine, Vol. 80, No. 3, 1974, p. 409-411.

Research output: Contribution to journalArticle

@article{7f659a246daa403b8eb367be174ecfe3,
title = "The granular type II pneumonocyte and lung antioxidant defense",
abstract = "Two cell types predominate in mammalian alveolar epithelium: Type I cells (membranous pneumonocytes), which have a small, nucleated cell body with attenuated peripheral cytoplasm containing a relative paucity of intracytoplasmic organelles, and which cover most of the alveolar surface; and Type II cells (granular pneumonocytes), which are nearly cuboidal with abundant cytoplasmic organelles, including moderate amounts of endoplasmic reticulum, ribosomes, and lamellar inclusions, and which cover areas of the alveolar surface not lined by type I cells. The lamellar inclusions of the type II cells represent sites of synthesis of pulmonary surfactant, the phospholipid rich substance primarily responsible for alveolar stability. The past few years have witnessed the ascendency of 3 other related concepts concerning the type II pneumonocyte: it participates in the injury and repair processes of pulmonary parenchymal tissue: it may be the progenitor of the more numerous type I alveolar epithelial cells; and the reparative adaptive response determines, to some extent, the susceptibility of lung parenchyma to oxidant stress. This editorial summarizes the 3 mutually complementary concepts.",
author = "Cross, {Carroll E}",
year = "1974",
language = "English (US)",
volume = "80",
pages = "409--411",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "3",

}

TY - JOUR

T1 - The granular type II pneumonocyte and lung antioxidant defense

AU - Cross, Carroll E

PY - 1974

Y1 - 1974

N2 - Two cell types predominate in mammalian alveolar epithelium: Type I cells (membranous pneumonocytes), which have a small, nucleated cell body with attenuated peripheral cytoplasm containing a relative paucity of intracytoplasmic organelles, and which cover most of the alveolar surface; and Type II cells (granular pneumonocytes), which are nearly cuboidal with abundant cytoplasmic organelles, including moderate amounts of endoplasmic reticulum, ribosomes, and lamellar inclusions, and which cover areas of the alveolar surface not lined by type I cells. The lamellar inclusions of the type II cells represent sites of synthesis of pulmonary surfactant, the phospholipid rich substance primarily responsible for alveolar stability. The past few years have witnessed the ascendency of 3 other related concepts concerning the type II pneumonocyte: it participates in the injury and repair processes of pulmonary parenchymal tissue: it may be the progenitor of the more numerous type I alveolar epithelial cells; and the reparative adaptive response determines, to some extent, the susceptibility of lung parenchyma to oxidant stress. This editorial summarizes the 3 mutually complementary concepts.

AB - Two cell types predominate in mammalian alveolar epithelium: Type I cells (membranous pneumonocytes), which have a small, nucleated cell body with attenuated peripheral cytoplasm containing a relative paucity of intracytoplasmic organelles, and which cover most of the alveolar surface; and Type II cells (granular pneumonocytes), which are nearly cuboidal with abundant cytoplasmic organelles, including moderate amounts of endoplasmic reticulum, ribosomes, and lamellar inclusions, and which cover areas of the alveolar surface not lined by type I cells. The lamellar inclusions of the type II cells represent sites of synthesis of pulmonary surfactant, the phospholipid rich substance primarily responsible for alveolar stability. The past few years have witnessed the ascendency of 3 other related concepts concerning the type II pneumonocyte: it participates in the injury and repair processes of pulmonary parenchymal tissue: it may be the progenitor of the more numerous type I alveolar epithelial cells; and the reparative adaptive response determines, to some extent, the susceptibility of lung parenchyma to oxidant stress. This editorial summarizes the 3 mutually complementary concepts.

UR - http://www.scopus.com/inward/record.url?scp=0016043791&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0016043791&partnerID=8YFLogxK

M3 - Article

C2 - 4816185

AN - SCOPUS:0016043791

VL - 80

SP - 409

EP - 411

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 3

ER -